Dagmar Makalová

No ORCID on file · 2 papers in corpus
article 2013
·doi:10.3109/13625187.2013.780202

OBJECTIVE: To summarise all clinical data on the contraceptive efficacy and bleeding profile associated with an oestradiol valerate (E2V) and dienogest (DNG) [E2V/DNG] combined oral contraceptive (COC) derived from Phase III trials. METHODS…

article 2009
·doi:10.1016/j.contraception.2009.03.018

BackgroundThis study compared the bleeding pattern, cycle control and safety of an oral contraceptive (OC) comprising estradiol valerate/dienogest (E2V/DNG; administered using a dynamic dosing regimen) with a monophasic OC containing ethiny…